Introduction {#Sec1}
============

Mild cognitive impairment (MCI) is a controversial clinical entity, initially conceptualized as a transitional zone between normal aging and dementia. The most commonly used criteria for MCI---also known as Mayo criteria---were proposed by Petersen *et al*. \[[@CR1],[@CR2]\]. These criteria require (1) a memory complaint, (2) normal activities of daily living, (3) normal general cognitive function, (4) abnormal memory for age and (5) absence of dementia. These criteria have been modified to expand the original MCI concept, including impairments in cognitive domains other than memory. Thus, the clinical phenotypes of amnestic MCI and nonamnestic MCI have been developed, which can both be further classified as single-domain or multiple-domain \[[@CR3]\]. Discussion about the MCI criteria and their operationalization is ongoing \[[@CR4]\], as the criteria neither specify methods to assess cognitive or functional capacity nor provide cutoff points for cognitive or functional scales to differentiate MCI from mild dementia.

Another important point of discussion is the existence of deficits in activities of daily living (ADL). ADL are divided into basic activities of daily living (BADL) and instrumental activities of daily living (IADL). BADL include self-maintenance skills such as bathing, getting dressed or eating, and IADL consist of more complex activities such as using public transportation, managing finances, or shopping \[[@CR5]\]. The assessment of ADL is usually done by using rating scales, which are administered either to the patient or a proxy. Controversy exists about the ability of patients with MCI to adequately rate themselves, as they lack awareness of IADL deficits and overestimate their functional capacity \[[@CR6]-[@CR8]\]. Farias *et al*., however, reported no lack of awareness in patients with MCI compared with healthy controls \[[@CR9]\]. There is evidence that proxies are not always a reliable source of information, as they have a tendency to over- or underestimate IADL deficits \[[@CR8],[@CR10],[@CR11]\]. In some cases, a proxy is not available or has massive knowledge gaps. Direct measures requiring the patient to solve specific IADL-related tasks have better validity and do not have reporter bias. However, they allow observation of only a small excerpt of real-world performance and are quite time-consuming.

It is assumed that IADL require more complex neuropsychological processing capacity than BADL and therefore are more prone to deterioration triggered by cognitive decline \[[@CR12],[@CR13]\]. Functional deficits have been observed early in the course of decline \[[@CR14]-[@CR16]\]. In an analysis of studies with a focus on BADL and IADL in subjects with MCI, dementia or no cognitive deficits, Nygård \[[@CR17]\] suggested that IADL can be impaired before the onset of dementia and should therefore be included in the diagnosis of MCI.

These findings were taken into account by Winblad *et al*. \[[@CR18]\], who proposed the following criteria for MCI: (1) not normal, not demented; (2) cognitive decline; and (3) preserved BADL and/or minimal impairment in complex instrumental functions. Thus, the criterion of "normal activities of daily living" has been revised to a less stringent one allowing for discrete IADL deficits in patients with MCI.

Over the last 15 years, a large amount of research has been conducted on IADL deficits in MCI. The aim of the present review is to summarize research results regarding the performance of patients with MCI in specific IADL (sub)domains compared with persons who are cognitively normal and/or patients with dementia. In addition, sample characteristics and applied IADL assessment methods---performance-based instruments versus self- and/or informant-reported questionnaires or interviews---are investigated.

Methods {#Sec2}
=======

Data sources {#Sec3}
------------

To identify relevant published papers, the electronic databases PubMed, Web of Science and PsycINFO were searched in December 2013. Publication dates were set from January 1999 to December 2013. This restriction was chosen to identify only papers that were published after the introduction of Petersen's MCI definition \[[@CR2]\]. The search terms "mild cognitive impairment" (MeSH term) or "MCI" were used in combination with the terms "activities of daily living" (MeSH term) or "ADL" or "instrumental activities of daily living" or "IADL" or "everyday functioning" or "functional ability" or "functional capability" or "functional deficits" or "functional impairment." After removal of duplicates, 497 articles were retrieved from the 3 searched databases.

Selection criteria {#Sec4}
------------------

Titles and abstracts of the retrieved articles were screened by two authors (KJ and MD) independently and were rated to assess their relevance to the research question. If inconsistencies occurred, a third author (LH) was consulted. The following selection criteria were applied. (1) The abstract indicated that the focus of the study was the investigation of IADL in MCI versus healthy controls and/or dementia patients. (2) General IADL and/or specific subdomains were investigated. (3) The method of IADL assessment was standardized. (4) MCI was defined according to Petersen and/or Winblad criteria \[[@CR2],[@CR3],[@CR18]\]. (5) No other concepts, such as cognitive impairment, no dementia \[[@CR19],[@CR20]\], aging-associated cognitive decline \[[@CR21]\] or age-associated memory impairment \[[@CR22]\], were used. (6) The original article was written in English.

Articles that met the outlined criteria were included in the present review. Reference lists of the selected articles were searched to retrieve further relevant articles. Effect sizes (Cohen's *d*) were calculated to allow a better evaluation of clinical relevance.

Results {#Sec5}
=======

In total, 34 of the 497 papers were selected for review. Owing to the broad focus of the search terms to ensure retrieval of all relevant articles, the majority of articles did not meet the inclusion criteria (that is, no definition of MCI criteria, use of concepts other than Petersen and/or Winblad criteria). A further three articles were selected from among the reference lists of the selected papers. Thus, the content of the present review is formed from a total of 37 articles.

Mild cognitive impairment sample characteristics {#Sec6}
------------------------------------------------

For the diagnosis of MCI, the criteria of Petersen or Winblad were applied across studies; their operationalization, however, varied. One-third of the studies used the original Petersen criteria supplemented by cutoffs on specific neuropsychological tests \[[@CR15],[@CR23]-[@CR34]\]. In the remaining studies, the use of the original clinical criteria published by Petersen *et al*. \[[@CR2]\] was reported without specific cutoff values or with a combination of Petersen and Winblad criteria. Mean Mini Mental State Examination (MMSE) \[[@CR35]\] scores ranged from 23.1 \[[@CR36]\] to 28.7 points \[[@CR37]\] for MCI samples, from 26.5 \[[@CR36]\] to 29.4 points \[[@CR30],[@CR38]\] for normal control samples and from 16.4 \[[@CR39]\] to 25.5 points \[[@CR40]\] for Alzheimer's disease (AD) samples. In each examined study, however, the MMSE score for the MCI group was lower than that for the comparative control group and higher than that for the dementia sample.

Study types and/or designs {#Sec7}
--------------------------

The majority of the reported studies followed a cross-sectional design (29 studies \[[@CR15],[@CR23]-[@CR26],[@CR29],[@CR30],[@CR33],[@CR34],[@CR36]-[@CR38],[@CR40]-[@CR56]\]), and eight studies applied a longitudinal design \[[@CR27],[@CR28],[@CR32],[@CR57]-[@CR61]\]. In five of the longitudinal studies, risk of conversion to AD depending on IADL impairment was also assessed \[[@CR27],[@CR28],[@CR32],[@CR58],[@CR60]\].

Assessment instruments used {#Sec8}
---------------------------

Altogether, 31 different instruments were used to assess IADL in patients with MCI (see Table [1](#Tab1){ref-type="table"} for details), including performance-based instruments, self- and informant-report rating questionnaires, and structured interviews. Of the 37 studies, 15 relied solely on informant-report rating questionnaires \[[@CR23],[@CR28],[@CR29],[@CR31],[@CR33],[@CR40]-[@CR43],[@CR45]-[@CR48],[@CR54],[@CR58]\], 10 relied solely on performance-based assessments \[[@CR24],[@CR26],[@CR30],[@CR32],[@CR38],[@CR50]-[@CR53],[@CR57]\] and 6 relied solely on self-report rating instruments \[[@CR27],[@CR36],[@CR55],[@CR56],[@CR59],[@CR61]\]. Three studies used both informant-report questionnaires and performance-based assessments \[[@CR25],[@CR34],[@CR60]\]. Interestingly (and inconsistently), in three studies \[[@CR15],[@CR25],[@CR44]\], the IADL of patients with MCI were rated by informants, whereas normal control subjects rated their IADL functioning themselves.Table 1**Instruments used for instrumental activities of daily living assessment** ^**a**^**AbbreviationFull instrument nameTypeIADL domainsPsychometric properties***Performance-based assessment instruments*DAFS \[[@CR62]\]Direct Assessment of Functional StatusP6 domains: time orientation, communication, financial skills, shopping, grooming, eatingGood interrater and test--retest reliability, good evidence of discriminant and convergent validity, ceiling effects for time orientation, identify change and shoppingDOT \[[@CR34]\]Day-Out TaskP8 tasks to prepare a day out (including packing a picnic basket, planning a bus route, gathering correct change for bus ride)Interrater reliability: 96.92% agreementEPT \[[@CR63]\]Everyday Problems TestPProblem solving related to medication use, meal preparation, telephone use, shopping, financial management, household management, transportationTest--retest reliability: *r* = 0.93, internal consistency (Cronbach's α) = 0.88. Validity: significant correlations with direct observation of older adults' performance of everyday tasks (*r* = 0.67), older adults' self-reports (*r* = 0.23) and dementia patients' self-reports (*r* = 0.36)FCI \[[@CR64]\]Financial Capacity InstrumentP7 domains: basic monetary skills, financial conceptual knowledge, cash transactions, checkbook management, bank statement management, financial judgment, bill paymentFor all subdomains: test--retest reliability *r* \> 0.8, internal consistency (Cronbach's α) \> 0.8META \[[@CR53]\]Management of Everyday Technology AssessmentP10 technology-related items (including performing actions in a logical sequence, turning a button)Acceptable person response validityTFLS \[[@CR65]\]Texas Functional Living ScaleP5 domains: time/orientation, money, communication, dressing, memoryTest--retest reliability: *r* = 0.93 in AD sample, test--retest reliability in control group: *r* = 0.52, strong correlation with MMSE scores (*r* = 0.92)TIADL \[[@CR66]\]Timed Instrumental Activities of Daily LivingP5 domains: shopping, finances, medication, telephone use, locating information on food labels (speed and accuracy)Test--retest reliability: *r* = 0.85UAB-DA \[[@CR67]\]University of Alabama at Birmingham Driving AssessmentPReal-world, standardized route: lane control, gap judgment, turning, maintaining proper speed, stopping distance, signaling, obeying traffic signs, preturn and postturn position, spacing, steer steadiness, precrossing and postcrossing position, and proper scanning of driving spaceNot reportedUCSD-UPSA \[[@CR68]\]University of California San Diego Performance-Based Skills AssessmentP5 domains: household chores, communication, finances, transportation, planning recreational activitiesTest--retest reliability: *r* = 0.92VAPS \[[@CR52]\]Virtual Action Planning SupermarketPVirtual reality supermarket, 8 parameters: total distance, total time in seconds, number of items purchased, number of correct actions, number of incorrect actions, number of pauses, combined duration of pauses, time to payValidity (correlations between VAPS performance and executive functions): *r* = −0.40 to *r* = −0.63*Self-report and informant-report rating instruments*ADCS-ADL \[[@CR69]\]Alzheimer's Disease Cooperative Study/Activities of Daily Living InventoryI23 items (including shopping, hobbies, personal appliances; both IADL and BADL)Moderate to good retest reliability, floor effects for financial abilities in individuals with dementiaADCS-MCI-ADL-18 \[[@CR69]\]18-item Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairmentI18 items (including shopping, hobbies, personal appliances; both IADL and BADL)Not reportedADCS-MCI-ADL-24 \[[@CR45]\]24-item Alzheimer's Disease Cooperative Study/Activities of Daily Living scale adapted for patients with mild cognitive impairmentI24 items (original ADCS-MCI-ADL scale plus 6 MCI-specific items, including driving a car, organizing medication)Not reportedADL-PI \[[@CR70]\]Activities of Daily Living-Prevention InstrumentI15 items (including completing and/or organizing activities, taking medication, using telephone, finding belongings, managing finances)Retest reliability: from *r* = 0.69 to *r* = 0.74Bayer-ADL \[[@CR71]\]Bayer Activities of Daily Living ScaleI25 items (2 BADL items, 18 specific IADL items, 5 items for cognitive functions)Internal consistency (Cronbach's α \> 0.98)DAD \[[@CR72]\]Disability Assessment for DementiaIIADL part with 23 items (meal preparation, telephoning, going on an outing, finances, medication, housework, leisure) and BADL part with 17 itemsInternal consistency (Cronbach's α = 0.96), interrater reliability (ICC = 0.95), test--retest reliability (ICC = 0.96)DAD-6 \[[@CR40]\]6-item Disability Assessment for DementiaI6 items: meal preparation, telephoning, going on an outing, handling finances and correspondence, medication, leisure, houseworkNot reportedDHQ \[[@CR59]\]Driving Habits QuestionnaireSDriving difficulty in 8 different situations and driving frequencyRetest reliability: from *r* = 0.65 to *r* = 0.86 for the 8 situationsETUQ \[[@CR56]\]Everyday Technology Use QuestionnaireS86 items (including questions about technology at home and outside, communication)Acceptable levels of internal scale validity, unidimensionality, and person response validityFAQ \[[@CR73]\]Functional Activities QuestionnaireS/I10 items (including finances, shopping, remembering appointments, playing games, preparing a meal, traveling, remembering appointments)Not reportedFC-ADL \[[@CR74]\]Functional Capacities for Activities of Daily LivingI50 statements reflecting possible IADL difficultiesNot reported4-IADL \[[@CR27]\]4 IADL scale items chosen from Lawton and Brody's Instrumental Activities of Daily Living \[[@CR5]\]S4 items: telephone use, finances, medication, transportationNot reported9-IADL \[[@CR58]\]9-item IADL scaleI9 items: medication responsibility, ability to buy food, to prepare meals, to keep the home clean, to use the telephone, to handle finances, to use public transportation, to orientate oneself outside, to visit peopleNot reportedIQCODE \[[@CR75]\]Informant Questionnaire on Cognitive Decline in the ElderlyI26 items (including finances, communication, memory, household appliances)Cronbach's α = 0.96, correlation with MMSE (*r* = 0.74)KI-IADL \[[@CR34]\]Knowledgeable Informant report about Instrumental Activities of Daily LivingI50 questions assessing 10 IADL domains: using the phone, traveling, shopping, preparing meals, household activities, conversation, organization, social functioning, medication management, financial managementNot reportedL&B IADL \[[@CR5]\]Lawton and Brody's Instrumental Activities of Daily LivingS/I8 items: shopping, grooming, medication responsibility, handling finances, mode of transportation, telephone use, food preparation, telephone useInterrater correlation: *r* = 0.85ROIL \[[@CR76]\]Record of Independent LivingI37 items assessing 3 domains: activities, communication, behaviorNot reportedSR-IADL \[[@CR77]\]Self-report Instrumental Activities of Daily LivingSItems include handling money, keeping appointments, planning meals (IADL performance and difficulty)Reliability: *r* = 0.74S-IADL \[[@CR78]\]Seoul-Instrumental Activities of Daily LivingS/I15 items (including ability to prepare a balanced meal, remember appointments, ability to keep financial records, remember to take medication)Good reliability and validitySIB-R \[[@CR79]\]Scales of Independent Behavior--RevisedS/I13 subscales organized into 4 adaptive behavior clusters: (1) social interaction and communication, (2) personal living, (3) community living, (4) motor skillsSelf-report: internal consistency (Cronbach's α) = 0.92, test--retest reliability: *r* = 0.80Informant-report: internal consistency (Cronbach's α) = 0.95, test--retest reliability: *r* = 0.84T-ADLQ \[[@CR54]\]Technology--Activities of Daily Living QuestionnaireI7 subscales (self-care, household care, employment and recreation, shopping and money, travel, communication, technology)Cronbach's α = 0.86; validity: significant correlations with the MMSE (*r* = −0.70)^a^AD, Alzheimer's disease; ADL, Activities of daily living; BADL, Basic activities of daily living; I, Informant-report; IADL, Instrumental activities of daily living; ICC, Intraclass correlation coefficient; MMSE, Mini Mental State Examination; P, Performance-based; S, Self-report.

Mild cognitive impairment subtypes {#Sec9}
----------------------------------

According to Petersen *et al*. \[[@CR1]\], MCI has two major subtypes: amnestic and nonamnestic. Both can be further divided into single-domain and multidomain types. Among the 37 studies included in this review, IADL performance was analyzed between MCI subtypes in 8 studies \[[@CR23],[@CR31],[@CR33],[@CR37],[@CR40],[@CR48],[@CR58],[@CR61]\].

Instrumental activities of living in patients with mild cognitive impairment {#Sec10}
----------------------------------------------------------------------------

Among the 37 studies included in this review, all but 2 studies \[[@CR38],[@CR42]\] found IADL deficits in patients with MCI compared with control subjects without cognitive impairment on at least one applied instrument. In the following sections, we first report results of studies investigating global IADL (see Table [2](#Tab2){ref-type="table"}), then results of studies in which informant-report measures were used and studies using self-report measures (see Table [3](#Tab3){ref-type="table"}).Table 2**Studies investigating global instrumental activities of daily living functioning** ^**a**^**AuthorYearMCI criteriaNumber of subjectsMean age, yr (SD)Mean MMSE score (SD)IADL measures usedResults and effect sizes (Cohen's** ***d*** **)***Performance-based instruments*Binegar *et al*. \[[@CR57]\]2009Petersen30 MCIMCI 72.8 (7.9)MCI 27.3 (2.2)TFLSTotal score: MCI \< NC (*d* = 0.61); subscales: significant for memory subscale (*d* = 0.85), but not for time/orientation, money, communication, dressingClinical30 NCNC 73.7 (6.9)NC 29.2 (1.0)nssignificantGiovannetti *et al*. \[[@CR24]\]2008Petersen25 MCIMCI 72.2 (6.7)MCI 27.6 (1.4)NATTotal score: NC \> MCI \> AD; MCI versus NC: *d* = 1.05, MCI versus AD: *d* = 1.46\
Error score: NC \< MCI \< AD; MCI versus NC: *d* = 0.74, MCI versus AD: *d* = 1.781.5 SD below18 NCNC 73.1 (3.2)NC 28.5 (1.0)MMSE ≥2525 mild ADAD 73.6 (3.8)AD 22.4 (2.8)ns(NC = MCI) \> AD, *P* \< 0.05Goldberg *et al*. \[[@CR25]\]2010Petersen26 MCIMCI 77.5 (7.1)MCI 26.1 (2.3)UCSD-UPSAUCSD-UPSA: NC \> MCI \> AD; MCI versus NC: *d* = 0.86, MCI versus AD: *d* = 1.81\
ADCS-ADL: (NC = MCI ) \> AD; MCI versus AD: *d* = 1.811.5 SD below50 NCNC 68.8 (9.9)NC 28.5 (1.5)Additional informant-report: ADCS-ADL (NC: self-report)CDR 0.522 ADAD 78.4 (5.4)AD 20.3 (3.4)MMSE ≥24Pereira \[[@CR60]\]2010Petersen31 MCIMCI 72.6 (7.0)MCI 27.3 (2.3)DAFSDAFS total score NC \> MCI \> AD; MCI versus NC: *d* = 1.58, MCI versus AD: *d* = 2.18\
DAFS subdomains: NC \> MCI for finances and shopping, but not time orientation, communication, grooming, eating, which were worse only in AD;\
IQCODE total score: NC \> MCI \> AD; MCI versus NC: *d* = 1.00, MCI versus AD: *d* = 0.77Clinical32 NCNC 71.6 (5.6)NC 28.8 (1.5)26 ADAD 77.9 (6.0)AD 19.5 (5.5)Additional informant-report: IQCODEAD \> (MCI/NC)AD \< (MCI = NC)Schmitter-Edgecombe *et al*. \[[@CR34]\]2012Petersen38 MCIMCI 70.5 (8.6)Not reportedDOTDOT: MCI \< NC for completion time (*d* = 0.60) and accuracy (*d* = 0.61)1.5 SD below38 NCNC 69.3 (7.9)Additional informant-report: KI-ADLKI-ADL: MCI \< NC (*d* = 0.50)nsWadley *et al*. \[[@CR50]\]2008Petersen50 MCIMCI 70.0 (7.9)Not reportedTimed IADLMCI = NC for accuracyClinical59 NCNC 67.8 (7.1)MCI \< NC for speed (*d* = 0.75), significant subdomains telephone (*d* = 0.56), grocery (*d* = 0.75), medication (*d* = 0.51), nutrition information (*d* = 0.52)ns*Informant-report rating instruments*Ahn *et al*. \[[@CR41]\].2009Petersen/Winblad66 MCIMCI 70.8 (7.3)MCI 24.8 (3.1)Seoul-IADLMCI \< NC (*d* = 1.62)1.5 SD below61 NCNC 64.4 (5.6)NC 27.6 (1.4)CDR 0.5significantBoeve *et al*. \[[@CR42]\]2003Petersen13 MCIMCI 94.3 (2.6)MCI 26.8 (1.6)ROILMCI = NC, MCI \> dementia (*d* = 2.93)Clinical56 NCNC 93.8 (2.5)NC 27.9 (2.3)42 DementiaDementia 94.8 (2.6)Dementia 18.6 (5.0)nsAD \< (MCI = NC)Brown *et al*. \[[@CR15]\]2011Petersen394 MCIMCI 74.9 (7.4)MCI 27.0 (1.8)FAQ (NC: self-report)Severity of deficits: NC \> MCI \> AD; MCI versus NC: *d* = 1.04, MCI versus AD: *d* = 1.71\
Number of deficits: NC \< MCI \< AD; MCI versus NC: *d* = 1.28, MCI versus AD: *d* = 1.621.5 SD below229 NCNC 75.9 (5.0)NC 29.1 (1.0)CDR 0.5193 ADAD 75.3 (7.5)AD 23.3 (2.1)MMSE ≥24nssignificantJefferson *et al*. \[[@CR43]\]2008Petersen/Winblad38 MCIMCI 74.6 (7.5)MCI 28.0 (1.7)L&B IADLL&B IADL: MCI = NC, FC-ADL: MCI \< NC (*d* = 0.84)Clinical39 NCNCI 72.4 (5.5)NC 29.3 (0.9)FC-ADLnssignificantMariani *et al*. \[[@CR44]\]2008Petersen/Winblad132 MCIMCI 76.1 (5.8)MCI 25.7 (1.6)L&B IADL\
(MCI: informant-report, NC: self-report)MCI \< NC (*d* = 0.29)below normality cutoff249 NCNC 72.2 (7.5)NC 28.1 (1.2)significantsignificantPedrosa *et al*. \[[@CR45]\]2010Petersen/Winblad30 MCIMCI 75.7 (6.4)MCI 24.4 (3.3)ADCS-MCI-ADL-18 ADCS-MCI-ADL-24 L&B-IADLADCS-MCI-ADL-18: NC \> MCI \> AD; MCI versus NC: *d* = 1.39, MCI versus AD: *d* = 2.27\
ADCS-MCI-ADL-24: NC \> MCI \> AD; MCI versus NC: *d* = 1.67, MCI versus AD: *d* = 2.33\
L&B IADL: NC \> MCI \> AD; MCI versus NC: *d* = 2.0, MCI versus AD: *d* = 2.891 SD below31 NCNC 72.2 (8.0)NC 27.7 (3.0)33 ADAD 76.1 (7.5)AD 16.5 (5.2)Perneczky *et al*. \[[@CR47]\]2006Petersen/Winblad48 MCIMCI 69.2 (8.3)MCI 26.5 (2.3)ADCS-MCI-ADL-18 Bayer-ADL IQCODEADCS-MCI-ADL-18: MCI \< NC (*d* = 1.98)\
Bayer-ADL: MCI \< NC (*d* = 1.95)\
IQCODE: MCI \< NC (*d* = 1.09)1 SD below42 NCNC 66.7 (9.3)NC 29.3 (0.7)CDR 0.5nssignificantPerneczky *et al*. \[[@CR46]\]2006Petersen/Winblad45 MCIMCI 69.2 (8.3)MCI 26.9 (1.4)ADCS-MCI-ADL-18 Bayer-ADLADCS-MCI-ADL-18: MCI \< NC (*d* = 1.89)\
Bayer-ADL: MCI \< NC (*d* = 2.44)1 SD below30 NCNC 66.7 (9.3)NC 29.3 (0.7)CDR 0.5nsReppermund *et al*. \[[@CR29]\]2011Petersen293 MCIMCI 78.8 (4.7)MCI 28.0 (1.5)Bayer-ADLBayer-ADL total: MCI \< NC (*d* = 0.32)1.5 SD below469 NCNC 78.3 (4.7)NC 28.8 (1.2)Bayer-ADL high cognitive demand: MCI \< NC (*d* = 0.40)nsBayer-ADL low cognitive demand: MCI = NCReppermund *et al*. \[[@CR28]\]2013Petersen227 MCIMCI 78.6 (4.4)MCI 28.3 (1.4)Bayer-ADLBayer-ADL total: MCI \< NC (*d* = 0.39)1.5 SD below375 NCNC 77.9 (4.6)NC 28.9 (1.2)Bayer-ADL high cognitive demand: MCI \< NC (*d* = 0.40)\
Bayer-ADL low cognitive demand: MCI \< NC (*d* = 0.27), IADL performance at baseline predicted conversion to dementia at 2-year follow-upnssignificant*Self-report rating instruments*Kim *et al*. \[[@CR36]\]2009Winblad255 MCIMCI 72.0 (6.0)MCI 23.1 (4.5)Seoul-IADLMCI \< NC (*d* = 0.27)1 SD below311 NCNC 70.7 (6.0)NC 26.5 (3.3)significantsignificantPeres *et al*. \[[@CR27]\]2006Petersen285 MCITotal sample: 80.8 (5.6)Not reported4-IADLNC \> MCI \> dementia1.5 SD below828 NC149 dementia*Comparison of MCI subtypes: informant-report rating instruments*Aretouli *et al*. \[[@CR23]\]2010Petersen124 MCIMCI 76.3 (7.5)MCI 28.2 (1.3)ADL-PI IQCODEADL-PI: MCI \< NC, *P* \< 0.001; all MCI subgroups \< NC, *P* \< 0.001, md = sd; am = nonam\
IQCODE: MCI \< NC, *P* \< 0.001; true for all subgroups; multiple \> single, am = nonam1.5 SD below(36 asMCINC 72.4 (7.3)NC 29.3 (0.9)CDR 0.545 amMCIsignificantsignificant26 nasMCI17 namMCI)68 NCLuck *et al*. \[[@CR58]\]2011Winblad161 MCIMCI 81.9 (5.0)Not reported9 IADL items (Schneekloth and Potthoff \[[@CR80]\])MCI \< NC (aMCI = naMCI; aMCI \< NC (*d* = 0.17), naMCI = NC)\
MCI + IADL deficits: higher risk of conversion to dementia\
MCI + IADL: 47.4% versus MCI-IADL: 31.4%;\
NC + IADL: 26.7% versus NC-IADL: 8.0%1 SD below(36 asMCI(aMCI 81.6 (4.8),42 amMCInaMCI 82.2 (5.2))60 nasMCINC 81.2 (4.7)23 namMCI)ns723 NCde Rotrou \[[@CR40]\]2012Petersen53 MCIMCI 78.6 (7.3)MCI 26.2 (2.2)DAD-6NC \> MCI \> AD; MCI versus NC: *d* = 1.29, MCI versus AD: *d* = 1.66\
NC \> sdMCI (*d* = 1.59), sdMCI \> mdMCI (*d* = 1.37)Clinical(29 sdMCINC 80.9 (4.2)NC 29.1 (1.0)24mdMCI)Dementia 80.6 (6.2)Dementia 25.5 (1.8)55 NCnsAll significant31 DementiaTam *et al*. \[[@CR48]\]2007Petersen/Winblad54 asMCIasMCI 79.3 (6.1)asMCI 25.4 (3.0)DADIADL subscale: (NC = asMCI) \> amMCI \> AD; amMCI versus NC: *d* = 0.98, asMCI versus amMCI: *d* = 0.80, asMCI versus AD: *d* = 2.93, amMCI versus AD: *d* = 1.71CDR 0.593 amMCIamMCI 80.1 (6.5)amMCI 22.3 (3.1)1 SD below78 NCNC 77.1 (5.1)NC 27.2 (2.1)85 ADAD 84.5 (5.9)AD 17.9 (3.2)Teng *et al*. \[[@CR31]\]2010Petersen1108 MCIas 77.0 (9.2)as 27.8 (1.8)FAQNC \> asMCI/amMCI/nasMCI; asMCI = amMCI, nasMCI = namMCIMMSE ≥24(532 asMCIam 75.3 (8.5)am 27.4 (1.8)340 amMCInas 74.1 (8.6)nas 28.2 (1.7)162 nasMCInam 73.0 (6.8)nam 27.8 (1.5)74 namMCI)NC 74.8 (9.1)NC 29.0 (1.2)3,036 NCsignificantYeh *et al*. \[[@CR33]\]2011Petersen56 asMCIasMCI 77.5 (6.7)asMCI 26.6 (1.6)DADNC \> MCI (as = am) \> AD; asMCI versus NC: *d* = 0.9, amMCI versus NC: *d* = 1.06, asMCI versus AD: *d* = 2.23, amMCI versus AD: *d* = 1.91 SD below94 amMCIamMCI 78.9 (5.8)amMCI 25.8 (1.6)MMSE ≥2464 NCNC 76.5 (6.6)NC 28.5 (1.3)102 ADAD 79.6 (6.1)AD 20.9 (3.1)*Comparison of MCI subtypes: self-report rating instruments*Wadley *et al*. \[[@CR61]\]2007Petersen/Winblad84 aMCIaMCI 77.0 (7.0)aMCI 26.0 (1.9)IADL (Home Care questionnaire)IADL performance: aMCI/mdMCI \< NC, naMCI = NC; aMCI versus NC: *d* = 0.23, mdMCI versus NC: *d* = 0.31; aMCI \< naMCI: *d* = 0.23\
IADL difficulty: all MCI subgroups \< NC; aMCI versus NC: *d* = 0.57, naMCI versus NC: *d* = 0.27, mdMCI versus NC: *d* = 0.57; aMCI \< naMCI: *d* = 0.231.5 SD below171 naMCInaMCI 76.5 (6.2)naMCI 26.2 (2.1)89 mdMCImdMCI 78.8 (6.6)mdMCI 25.1 (1.8)2,110 NCNC 72.9 (5.4)NC 27.6 (1.8)significant*Comparison of MCI subtypes and all three types of instruments*Burton *et al*. \[[@CR37]\]2009Petersen/Winblad6 asMCIasMCI 79.5 (5.7)asMCI 26.8 (2.5)Performance-based: EPTSelf-report: SIB-R: NC \> mdMCI (*d* = 0.71), sdMCI \> mdMCI (*d* = 0.45), L&B: MCI = NC; L&B IADL: MCI = NC\
Informant-report SIB-R: NC \> sdMCI (*d* = 0.46), NC \> mdMCI (*d* = 0.51); L&B IADL: MCI = NC\
EPT: NC \> sdMCI \> mdMCI; sdMCI versus NC: *d* = 0.50, sdMCI versus mdMCI: *d* = 1.541 SD below39 nasMCInasMCI 77.5 (5.6)nasMCI 28.7 (1.3)Self-report: L&B IADL, SIB-R;\
Informant-report: L&B IADL, SIB-R19 amMCIamMCI 82.0 (5.0)amMCI 28.2 (1.3)28 namMCInamMCI 79.6 (4.9)namMCI 28.7 (1.1)158 NCNC 73.6 (4.7)NC 28.9 (1.2)^a^AD, Alzheimer's disease; ADCS-ADL, Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory; ADCS-MCI-ADL-18, 18-item Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment; ADCS-MCI-ADL-24, 24-item Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment; ADL, Activities of daily living; ADL-PI, Activities of Daily Living-Prevention Instrument; am, Amnestic multiple domain; aMCI, Amnestic mild cognitive impairment; as, Amnestic single domain; BADL, Basic activities of daily living; Bayer-ADL, Bayer Activities of Daily Living Scale; CDR, Clinical dementia rating; DAD, Disability Assessment for Dementia; DAD-6, 6-item Disability Assessment for Dementia; DAFS, Direct Assessment of Functional Status; DHQ, Driving Habits Questionnaire; DOT, Day-Out Task; EPT, Everyday Problems Test; ETUQ, Everyday Technology Use Questionnaire; FAQ, Functional Activities Questionnaire; FC-ADL, Functional Capacities for Activities of Daily Living; FCI, Financial Capacity Instrument; FC-IADL, Functional Capacities for Instrumental Activities of Daily Living; IADL, Instrumental activities of daily living; 4-IADL, 4-item Instrumental Activities of Daily Living scale items chosen from Lawton and Brody; 9-IADL, 9-item Instrumental Activities of Daily Living scale; ICC, Intraclass correlation coefficient; IQCODE, Informant Questionnaire on Cognitive Decline in the Elderly; KI-IADL, Knowledgeable Informant report about Instrumental Activities of Daily Living; L&B IADL, Lawton and Brody's Instrumental Activities of Daily Living; MCI, Mild cognitive impairment; md, Multiple domain; META, Management of Everyday Technology Assessment; MMSE, Mini Mental State Examination; nam, Nonamnestic multiple domain; naMCI, Nonamnestic mild cognitive impairment; nas, Nonamnestic single domain; NAT, Naturalistic action task; NC, Normal control; NIA-AA, National Institute on Aging and Alzheimer's Association; ns, nonsignificant; ROIL, Record of Independent Living; sd, Single domain; SD, Standard deviation; S-IADL, Seoul-Instrumental Activities of Daily Living; SIB-R, Scales of Independent Behavior--Revised; SR-IADL, Self-report Instrumental Activities of Daily Living; TADL-Q, Technology--Activities of Daily Living Questionnaire; TFLS, Texas Functional Living Scale; TIADL, Timed Instrumental Activities of Daily Living; UAB-DA, University of Alabama at Birmingham Driving Assessment; UCSD-UPSA, University of California, San Diego Performance-Based Skills Assessment; VAPS, Virtual Action Planning Supermarket.Table 3**Studies investigating specific instrumental activities of daily living domains** ^**a**^**AuthorYearMCI criteriaNumber of subjectsMean age, yr (SD)Mean MMSE score (SD)IADL measuresResults and effect sizes (Cohen's** ***d*** **)***Financial capacity: performance-based instruments*Griffith *et al*. \[[@CR26]\]2003Petersen21 MCIMCI 68.1 (8.8)MCI 28.4 (1.2)FCINC \> MCI \> AD; MCI versus NC: *d* = 1.14, MCI versus AD *d* = 1.21CDR 0.521 NCNC 66.7 (7.2)NC 29.3 (1.0)22 ADAD 71.5 (9.2), nsAD 24.1 (2.6)Sherod *et al*. \[[@CR30]\]2009Petersen113 MCIMCI 70.3 (7.4)MCI 28.1 (1.9)FCINC \> MCI \> AD; MCI versus NC: *d* = 1.03, MCI versus AD: *d* = 0.871.5 SD below85 NCNC 67.2 (8.2)NC 29.4 (0.9)43 ADAD 73.8 (8.5)AD 24.6 (2.9)all significantTriebel *et al*. \[[@CR32]\]2009Petersen87 MCIADcon 74.4 (6.0)ADcon 27.0 (1.9)FCINC \> MCI; ADnon versus NC: *d* = 0.83, ADcon versus NC: *d* = 1.831.5 SD below(25 ADcon, 62 ADnon)ADnon 68.5 (7.5)ADnon 28.6 (1.4)76 NCNC 66.7 (8.5)NC 29.4 (1.0)*Management of everyday technology: performance-based instruments*Malinowsky *et al*. \[[@CR53]\]2010Petersen33 MCIMCI 70.5 (8.4)MCI 27.5 (1.9)METANC \> MCI \> AD, MCI versus NC: *d* = 0.66, MCI versus AD: *d* = 1.2345 NCNC 73.2 (9.7)NC 29.3 (1.1)38 ADAD 75.3 (9.1)AD 23.5 (3.3)Malinowsky *et al*. \[[@CR38]\]2012Petersen/Winblad33 MCIMCI 70.8 (8.6)MCI 27.5 (1.9)METANC \> AD, MCI = NC42 NCNC 72.6 (9.7)NC 29.4 (1.0)35 ADAD 75.5 (9.2)AD 23.5 (3.4)ns*Management of everyday technology: informant-report rating instruments*Munoz-Neira *et al*. \[[@CR54]\]2012Winblad21 MCIMCI 71.3 (9.1)MCI 26.1 (2.5)T-ADLQTotal score: NC \> MCI \> AD, MCI versus NC: *d* = 0.62, MCI versus AD: *d* = 1.47\
Subscales: NC \> MCI on 2 subscales: employment and recreation: *d* = 0.54, travel: *d* = 0.5544 NCNC 74.1 (7.3)NC 27.8 (2.3)63 ADAD 73.9 (8.7)AD 17.9 (5.8)*Management of everyday technology: self-report rating instruments*Nygård *et al*. \[[@CR55]\]2011Petersen/Winblad37 MCIMCI 67.0 (7.47)MCI 27.5 (2.1)ETUQ (support of proxy possible for patients with AD and MCI)Perceived relevance of ET: NC \> MCI \> AD; MCI versus NC: *d* = 0.51, MCI versus AD: *d* = 1.2644 NCNC 69.0 (9.58)NC 29.1 (1.1)37 ADAD 72.0 (8.92)AD 25.4 (2.8)nsnsPerceived difficulty of ET: NC \< MCI \< AD; MCI versus NC: *d* = 0.82, MCI versus AD: *d* = 1.26Rosenberg *et al*. \[[@CR56]\]2009Petersen30 MCIMCI 74.0 (6.9)MCI 27.0 (2.4)ETUQ (support of proxy possible for patients with AD and MCI)Perceived relevance of ET: NC \> MCI = AD; MCI versus NC: *d* = 1.6693 NCNC 74.0 (7.6)NC 28.0 (1.7)Perceived difficulty of ET: NC \< MCI \< AD; MCI versus NC: *d* = 0.59, MCI versus AD: *d* = 1.0034 ADAD 73.0 (8.4)AD 24.0 (3.3)ns*Driving capacity: performance-based instruments*Wadley *et al*. \[[@CR51]\]2009Petersen46 MCIMCI 71.3 (7.8)Not reportedUAB-DAMCI \< NC, *d* = 0.4659 NCNC 67.1 (6.7)significant*Driving capacity: self-report rating instruments*O'Connor *et al*. \[[@CR59]\]2010Petersen/Winblad304 MCIMCI 76.8 (6.5)Not reportedDHQ(aMCI = naMCI = mdMCI) \< NC (driving frequency, driving difficulty, driving space) differed at baseline and faster rates of decline\
Driving frequency: aMCI versus NC: *d* = 0.31, naMCI versus NC: *d* = 0.24, mdMCI versus NC: *d* = 0.14\
Driving difficulty: aMCI versus NC: *d* = 0.35, naMCI versus NC: *d* = 0.36, mdMCI versus NC: *d* = 0.45\
Driving space: aMCI versus NC: *d* = 0.42, naMCI versus NC: *d* = 0.51, mdMCI versus NC: *d* = 0.431.5 SD below(82 aMCINC 72.6 (5.3)140 naMCIsignificant82 mdMCI)2,051 NC*Shopping capacity: performance-based instruments*Werner *et al*. \[[@CR52]\]2009Petersen30 MCIMCI 69.3 (7.4)MCI 27.5 (1.3)VAPSMCI \< NC; significant subscales: distance *d* = 0.29, trajectory duration: *d* = 1.16, duration of pauses: *d* = 0.8930 NCNC 69.6 (7.3)NC 29.4 (0.7)nssignificant^a^AD, Alzheimer's disease; ADcon, Converters to Alzheimer's disease; ADnon, Nonconverters to Alzheimer's disease; aMCI, Amnestic mild cognitive impairment, both single and multiple domains; CDR, Clinical dementia rating; DHQ, Driving Habits Questionnaire; ETUQ, Everyday Technology Use Questionnaire; FCI, Financial Capacity Instrument; MCI, Mild cognitive impairment; mdMCI, Multiple-domain mild cognitive impairment; NC, Normal control; ns, Nonsignificant; UAB-DA, University of Alabama at Birmingham Driving Assessment; VAPS, Virtual Action Planning Supermarket.

Global instrumental activities of daily living rating instruments {#Sec11}
-----------------------------------------------------------------

### Performance-based instruments {#Sec12}

Schmitter-Edgecombe *et al*. \[[@CR34]\] designed the Day-Out Task (DOT), which requires multitasking in a real-world setting. Participants have to prepare for a day out and complete related tasks such as planning a bus route or packing specific items in a picnic basket. Patients with MCI required more time to complete the DOT than healthy controls and made more errors while solving the subtasks. By means of the Timed IADL, Wadley *et al*. \[[@CR50]\] investigated both the speed and accuracy of patients with MCI in solving tasks related to shopping, finances, medication, telephone use and locating information on food labels. Patients with MCI took significantly longer than normal controls to solve the tasks and were less accurate. Using the Direct Assessment of Functional Status (DAFS), Pereira *et al*. \[[@CR60]\] found that patients with MCI performed significantly worse than healthy controls and better than AD patients. Financial and shopping skills were the items that differentiated patients with MCI from healthy controls. Binegar *et al*. \[[@CR57]\] applied the Texas Functional Living Scale and detected a significant but small difference between patients with MCI and controls. Interestingly, they mentioned that the performance of patients with MCI on this direct measure was much better (47 points) than that of patients with mild AD (31 points) in a previously conducted study \[[@CR65]\].

Using the Naturalistic Action Task, Giovanetti *et al*. \[[@CR24]\] found that patients with MCI performed significantly worse than healthy controls, but better than persons with mild AD, on all three assessed tasks: preparing toast and coffee, wrapping a gift and preparing a lunch box. When cutoff scores were applied, no controls, but 24% of the patients with MCI and 76% of the AD group, fell within the impaired range. Goldberg *et al*. found a similar pattern of results when they applied a novel performance-based assessment (the University of California San Diego Performance-Based Skills Assessment): The cognitively normal control group outperformed the MCI group, which in turn performed better than the mild to moderate AD group \[[@CR25]\]. Interestingly, using the informant-report Alzheimer's Disease Cooperative Study/Activities of Daily Living Inventory (ADCS-ADL), they detected no significant differences between patients with MCI and persons who were cognitively normal.

All of the performance-based instruments detected significant differences in IADL functioning between patients with MCI and healthy controls, as well as between patients with MCI and patients with dementia, respectively. Furthermore, patients with MCI needed more time to complete tasks than healthy controls and less time than patients with dementia. Calculated effect sizes were medium to large. In terms of effect sizes, the DAFS was the best measure for detecting differences in global IADL functioning between MCI and healthy controls (Cohen's *d* = 1.58) and between MCI and AD (Cohen's *d* = 2.18).

### Informant-report rating instruments {#Sec13}

Using the Seoul-IADL, Ahn *et al*. \[[@CR41]\] found deficits in patients with MCI compared with healthy controls in the domains of telephone use, meal preparation, medication intake, management of belongings, keeping appointments, talking about recent events and performing leisure activities and/or hobbies. They concluded that IADL requiring memory or frontal cortex executive functioning are at particular risk of decline in MCI. Jefferson *et al*. \[[@CR43]\] applied an error-based questionnaire of functional capacity (FC-IADL). The FC-IADL measures specific behaviors such as "getting lost in familiar places" and "does not use tools for the proposed use." On this questionnaire, patients with MCI scored more than 1.5 standard deviations (SD) worse than normal controls. In contrast, no statistically or clinically significant differences were found for the informant-report Lawton and Brody IADL scale.

In contrast, two other studies applying Lawton and Brody's IADL scale \[[@CR44],[@CR45]\] showed that patients with MCI had deficits compared with controls regarding shopping, taking medications and handling finances.

Using the Record of Independent Living, Boeve *et al*. \[[@CR42]\] found no significant differences between patients with MCI and healthy controls, but they did observe differences between patients with MCI and controls compared with dementia patients. This study is exceptional within this review because the participants were 90 to 100 years of age. Furthermore, the MCI group was very small (n = 13, compared with 56 healthy controls and 42 patients with dementia). Perneczky *et al*. \[[@CR47]\] applied a questionnaire specifically designed for measuring IADL in MCI---the ADCS-MCI-ADL \[[@CR69]\]---and found greater informant-reported impairments for the MCI group than among the age- and sex-matched cognitively normal controls. Pedrosa *et al*. \[[@CR45]\] also reported better ADCS-MCI-ADL scores for healthy controls than for patients with MCI. Consistent observations---that is, differences between patients with MCI and healthy controls---in both studies were observed for finding personal belongings, balancing a checkbook, keeping appointments, using a telephone and talking about recent events. Furthermore, Pedrosa et al. compared the original ADCS-MCI-ADL scale with an extended version. (The authors added six items that they considered useful for MCI populations.) The 24-item version distinguished patients with MCI and healthy controls more reliably than the 18-item version \[[@CR45]\]. Reppermund *et al*. \[[@CR29]\], using the Bayer-ADL scale, found significant differences between patients with MCI and healthy controls. This effect was due to deficits of patients with MCI in the domains of observing important dates or events, reading, describing recent events, taking part in a conversation, taking a message, doing two tasks at a time, coping with unfamiliar situations and performing a task while under pressure. Conducting a factor analysis, the authors further subdivided the items into IADL with high or low cognitive demands. Group differences emerged only for the high cognitive demand factor, which consisted mainly of the items mentioned above, which in turn were responsible for the group differences between healthy controls and MCI subjects. The low cognitive demand factor consisted of items such as shopping, using transportation and preparing food. The same work group \[[@CR28]\] gathered longitudinal data and again found differences in the Bayer-ADL scale between patients with MCI and healthy controls at baseline and at 2-year follow-up. For healthy controls, Bayer-ADL items with high cognitive demand predicted conversion to MCI and dementia at follow-up. Using the Functional Activities Questionnaire (FAQ), Brown *et al*. \[[@CR15]\] detected significant differences between patients with MCI and healthy controls, and patients with MCI showed more deficits than healthy controls regarding financial skills and remembering events.

With the exception of one study \[[@CR42]\], differences between patients with MCI and healthy controls were consistently detected. Deficits regarding financial abilities and memory-related IADL such as keeping appointments or remembering events were common themes across studies. With large effect sizes and consistent results across studies, the informant-reported ADCS-MCI-ADL seems to be a useful tool for global IADL assessment. The Lawton and Brody IADL scale delivered mixed results. Jefferson *et al*. detected no significant differences between MCI and healthy controls \[[@CR43]\], whereas Pedrosa *et al*. found large effects \[[@CR45]\] and Mariani *et al*. discovered small effects \[[@CR44]\]. The same holds true for the Bayer-ADL. Large effects were seen in the two studies by Perneczky *et al*. \[[@CR46],[@CR47]\], but only small effects were reported in the studies by Reppermund *et al*. \[[@CR28],[@CR29]\].

### Self-report rating instruments {#Sec14}

Using the Seoul-IADL in a self-rating version, Kim *et al*. \[[@CR36]\] found patients with MCI to be significantly impaired in using a telephone, keeping appointments, talking about recent events and using household appliances, thus replicating the findings of Ahn *et al*. with the Seoul-IADL in an informant-rating version \[[@CR41]\]. In addition, Kim *et al*. also reported worse performance of the MCI group for transportation and finances. Peres *et al*. \[[@CR27]\] investigated restriction to four IADL items from the Lawton and Brody IADL scale in a self-rating version: telephone use, mode of transport, medication responsibility and handling finances. Patients with MCI were more often restricted in IADL (34.3%) than controls (5.4%) and were less restricted than patients with dementia (91.1%). Interestingly, within a 2-year period, IADL-restricted patients with MCI converted to dementia more frequently than IADL-nonrestricted patients with MCI (30.7% versus 7.8%).

Global instrumental activities of daily living and mild cognitive impairment subtypes {#Sec15}
-------------------------------------------------------------------------------------

When we analyzed MCI subtypes, differences between MCI subtypes and normal controls were reported for all applied measures except of the Lawton and Brody IADL scale. Looking at effect sizes, the IADL deficits tended to be more pronounced in multiple-domains MCI than in single-domain MCI and also in amnestic MCI than in nonamnestic MCI.

### Informant-report rating instruments {#Sec16}

Focusing on MCI subtypes, Tam *et al*. \[[@CR48]\] found that the multiple-domains MCI subgroup had an intermediate IADL performance level between those of normal controls and patients with mild dementia on the Disability Assessment for Dementia (DAD) scale. Using the DAD, IADL performance, as well as subjects' performance regarding initiation or planning and organizing of the IADL subtasks, can be evaluated. The amnestic MCI group had significantly better IADL scores than the multiple-domains MCI group, and their scores were similar to those of the cognitively normal controls. The IADL subscales most frequently impaired in the multiple-domains MCI group were those connected to planning and organizing IADL tasks; initiation of tasks was unaffected.

Aretouli *et al*. \[[@CR23]\] found significant differences between healthy controls and patients with MCI for 12 of 15 items on the Activities of Daily Living-Prevention Instrument. Major difficulties were reported for keeping appointments, using the telephone, remembering current events and finding things at home, and minor difficulties were reported for driving and using transportation, managing finances, organizing and completing activities, and taking medication. An analysis of the MCI subtypes revealed that all four subgroups showed deficits compared with normal controls. However, patients with multiple-domains MCI were not significantly different from those with single-domain MCI, and the amnestic groups did not differ significantly from the nonamnestic groups.

Using the DAD, Yeh *et al*. \[[@CR33]\] reported more IADL deficits for both single-domain amnestic MCI und multiple-domains amnestic MCI than for healthy controls. Both MCI groups had better DAD scores than the mild AD group. When they looked at the DAD scores in detail, though, multiple-domains amnestic patients with MCI had deficits on a larger number of items than single-domain amnestic patients with MCI. Applying the DAD-6 (a shortened version of the DAD), de Rotrou *et al*. \[[@CR40]\] reported similar findings. Using the FAQ, Teng *et al*. \[[@CR31]\] reported better results for normal controls than for patients with MCI. In analyzing the subgroups, they found better results for normal controls than for the amnestic MCI group on all investigated IADL items and better scores than the nonamnestic group on managing bills, preparing taxes, keeping up with current events, attending to media, remembering dates and traveling outside the neighborhood. Luck *et al*. \[[@CR58]\] investigated performance on nine IADL items and detected worse performance of patients with MCI compared with healthy controls. Analyses of MCI subtypes revealed that this effect was stronger for amnestic MCI subtypes.

### Self-report rating instruments {#Sec17}

Investigating MCI subtypes and normal controls, Wadley *et al*. \[[@CR61]\] found all MCI subgroups reported significantly greater IADL difficulty and worse everyday functioning scores than normal controls at baseline. Over a 3-year period, all MCI groups also showed a significantly steeper decline on the everyday-functioning composite score and IADL performance compared with the cognitively normal group.

### One study comparing all three assessment modalities {#Sec18}

In a study by Burton *et al*. \[[@CR37]\], three different IADL measures were used that revealed differences between MCI subtypes and healthy controls on the Scales of Independent Behavior--Revised (on both the self- and informant-report version) and the performance-based Everyday Problems Test. No differences between groups emerged with the use of Lawton and Brody's IADL scale with either the self-report or the informant-report version.

Specific instrumental activities of daily living domains {#Sec19}
--------------------------------------------------------

### Financial capacity performance-based instruments {#Sec20}

Financial capacity is the best-studied IADL subdomain. The Financial Capacity Instrument (FCI) has been used in three studies \[[@CR26],[@CR30],[@CR32]\]. The FCI assesses financial capacity in seven domains, including monetary skills, financial concepts and bank statement management. All three studies revealed that the overall financial capacity (total score) of patients with MCI was worse than that of healthy controls. The activity "bank statement management" was consistently affected across studies. Griffith *et al*. \[[@CR26]\] additionally found group differences regarding bill payment and financial concepts. Moreover, Triebel *et al*. \[[@CR32]\] reported longitudinal data showing that, at baseline, MCI participants were significantly worse than normal controls on all financial domains and on total scores. Furthermore, the MCI group had been divided into converters and nonconverters to dementia. At baseline, the MCI nonconverter group performed better than the converter group in the domains of financial conceptual knowledge, cash transactions, bank statement management, bill payment and both total scores. No differences were observed for the domains of basic monetary skills, checkbook management, financial judgment and investment decision-making. Over a 1-year period, declines in the domain checkbook management and the total score were observed for the converters, but not for the nonconverters or controls \[[@CR32]\].

### Management of everyday technology {#Sec21}

#### Performance-based instruments {#FPar1}

In 2010, Malinowsky *et al*. \[[@CR53]\] used a standardized observation-based tool (Management of Everyday Technology Assessment) to evaluate ability to manage everyday technology (ET; for example, electronic household appliances, remote controls, cell phones) in patients with mild AD or MCI and controls. They found significant differences between all three groups. Patients with MCI performed worse in using technology than healthy controls did, but better than patients with dementia. In a more recent analysis of the same sample by the same work group \[[@CR38]\], significant differences were observed only between healthy controls and patients with dementia when intrapersonal and environmental features were controlled for. They reasoned that what influences a person's ability to use ET---besides cognitive level or diagnosis---is within-person variability in intrapersonal characteristics and environmental influence (that is, the design of the ET and the context in which it is used).

#### Informant-rating instruments {#FPar2}

Muñoz-Neira *et al*. \[[@CR54]\] added a technology subscale to a Spanish ADL questionnaire. They found significant group differences between healthy controls, patients with MCI and patients with dementia for the total score. Patients with AD had worse scores than patients with MCI and healthy controls on all seven subscales. Comparing patients with MCI and healthy controls, only the recreation and travel subscales differed significantly; no difference was observed for the technology subscale.

#### Self-report rating instruments {#FPar3}

Applying the Everyday Technology Use Questionnaire, Rosenberg *et al*. \[[@CR56]\] investigated the perceived difficulty in use of everyday technologies in samples with AD, MCI and controls. They found significant differences between groups, as well as in the amount of technologies that were considered relevant in each group. Using the same instrument, Nygård *et al*. \[[@CR55]\] could replicate the above-mentioned findings. Furthermore, they found a moderately strong association between engagement in everyday life activities and perceived difficulty in ET use in these three samples.

### Driving capacity {#Sec22}

#### Performance-based instruments {#FPar4}

Wadley *et al*. \[[@CR51]\] investigated driving ability, which revealed that patients with MCI were significantly more likely than participants who were cognitively normal to be given "less than optimal" ratings for left-hand turns, lane control and the global driving rating. Furthermore, they tended to receive more "less than optimal" ratings on gap judgment and maintaining proper speed. No differences were found for right-hand turns or steering steadiness. The authors noted, however, that the magnitude of difference between MCI participants' driving performance and that of controls was small, and that, as a group, MCI drivers were not sufficiently impaired to have their driving ability rated as unsafe or unsatisfactory.

#### Self-report rating instruments {#FPar5}

O'Connor *et al*. \[[@CR59]\] investigated 5-year trajectories of mobility indicators, including driving frequency and perceived driving difficulty. The study revealed that driving frequency had a steeper decline in the MCI group compared with healthy controls. Furthermore, driving in both normal and demanding situations was perceived as more difficult by patients with MCI than controls.

### Shopping capacity performance-based instruments {#Sec23}

Werner *et al*. \[[@CR52]\] directly assessed the IADL domain of shopping by means of a virtual reality supermarket scenario (the Virtual Action Planning Supermarket). They found that patients with MCI covered a significantly higher mean distance, had longer pauses and accordingly took longer to complete their shopping than normal controls. However, the number of purchases, correct or wrong actions, stops and mean time to pay did not differ between groups.

Discussion {#Sec24}
==========

This review impressively illustrates that deficits in IADL are consistently present in MCI. Of the 37 included studies, 35 revealed deficits in global IADL or in specific IADL subdomains such as finances, shopping, keeping appointments, driving or ET use. Furthermore, compared with healthy controls, patients with MCI needed longer to complete tasks and tended to be less accurate. Effect sizes were predominantly moderate to large. In analyzing the MCI subtypes, we observed that the IADL deficits tended to be more pronounced in multiple-domains MCI than in single-domain MCI and in amnestic MCI than in nonamnestic MCI, respectively.

In general, patients with MCI had intermediate functional performance between healthy controls and patients with mild AD, particularly in more complex tasks with high cognitive demand. Financial capacity, particularly, was affected in a vast majority of studies. On the general IADL questionnaires, telephone use, responsibility for medication and keeping appointments were the domains most often affected. Nevertheless, there were studies that revealed no deficits in these domains \[[@CR37],[@CR42]\]. Even when comparing studies in which researchers used the same instrument, such as the Seoul-IADL \[[@CR36],[@CR41]\], only three matching domains emerged: telephone use, keeping appointments and using household appliances. Similar inconsistencies were observed for Lawton and Brody's IADL Scale \[[@CR5]\]. In two studies in which this instrument was used, investigators did not find any differences between patients with MCI and persons who were cognitively normal \[[@CR37],[@CR43]\], supporting the argument that this scale is not sensitive enough to detect subtle deficits in MCI. However, researchers in two other studies \[[@CR44],[@CR45]\] used the same scale and identified impairments in patients with MCI regarding the domains of shopping, medication and finances. One possible explanation for these inconsistencies is the very heterogeneous operationalization of the MCI criteria. Some studies relied solely on a clinical decision, and others used cutoff scores to determine the magnitude of cognitive impairment, but even the cutoff scores varied between 1 SD and 1.5 SD below age- and education-adjusted norms. Furthermore, the mean MMSE scores of MCI subjects ranged from 23.1 \[[@CR36]\] to 28.7 points \[[@CR37]\], and mean MMSE scores of normal controls ranged from 26.5 \[[@CR36]\] to 29.4 points \[[@CR30]\]. The problem with studies including patients with MCI with very low MMSE scores is that IADL deficits may be due to already present, but not yet diagnosed, dementia. In a long-term study of patients with mild AD (MMSE score range, 20 to 26), 45% to 65% could not perform usual IADL tasks at baseline, and 70% to 85% of the remaining patients needed assistance with IADL after 3 years \[[@CR81]\]. For future research, it would be helpful to conduct (sub)analyses with patients with MCI who have a MMSE score of 27 points or higher to ensure that they have not already converted to dementia. Another possibility is to use cutoff scores of 1 SD, instead of 1.5 SD, below age- and education-adjusted norms in neuropsychological tests \[[@CR82]\]. Moreover, it should be taken into consideration that the MMSE is a rather insensitive measure for cognitive functioning, as it is not adjusted for age and education. In general, the use of MMSE cutoff scores to define MCI should be scrutinized.

In reviewing the selected articles, we found that the variety of assessment instruments applied to assess IADL in MCI was impressive; 31 different instruments were identified (see Table [1](#Tab1){ref-type="table"}), which complicates comparisons among studies. Another problem is that few of these instruments were constructed and validated for IADL assessment in patients with MCI. The majority of the instruments used were originally designed for studies with patients with dementia, and thus the items are not calibrated to detect subtle differences from normal. Moreover, data on psychometric properties are mainly insufficient; for an overview of IADL scales in dementia where the need for validation studies is explicated, see the article by Sikkes *et al*. \[[@CR83]\]. Measures specifically designed for MCI populations are required. This may be exemplified by the failure of the ADCS-ADL scale to reveal differences between patients with MCI and healthy controls \[[@CR25]\], whereas the ADCS-MCI-ADL scales definitely detected differences \[[@CR46],[@CR47]\]. The problem could be solved by constructing more sensitive item scoring for MCI-specific scales and/or by investigating in detail only those domains that have been shown to be impaired consistently in MCI, such as financial capacity. When the domain of financial capacity was thoroughly analyzed by an interview or a performance-based assessment procedure, differences between patients with MCI and control participants with cognitive impairment were persistently observed \[[@CR26],[@CR32],[@CR39]\] and invariably revealed large effect sizes.

Furthermore, the majority of assessment instruments do not investigate computer skills or the handling of "new" technology in general. The instruments targeting ET use are examples of scales that focus on a particular domain that proved to be sensitive to subtle impairment, and significant differences were detected through both self-reports and observations \[[@CR53]-[@CR56]\].

Performance-based assessment methods seem to be a promising tool, especially for patients without proxies to provide information about the patient's IADL. Moreover, performance-based methods would overcome another methodological issue related to self- and/or informant-report measures. In three reviewed studies \[[@CR15],[@CR25],[@CR44]\], healthy controls rated their IADL capacity themselves, whereas MCI subjects were rated by their proxies. This inconsistency could lead to biased results, as rating procedures differed. All assessment methods have their limitations. When using self-report, patients tend to over- or underestimate their abilities and may not have full insight into the impairments caused by the disease. Informant-based methods rely on the informant's knowledge about the patient, which might be affected by the amount of care provided. In addition, family members tend to misjudge the patient's capacity. Performance-based instruments also have limitations, such as a higher degree of training needed by assessors, a more time-consuming evaluation and an unfamiliar environment that might bias the functional performance \[[@CR84]\].

Furthermore, this review revealed some main problems of MCI definition. The operationalization of MCI is not clearly specified, which leads researchers to define cutoff points and choose assessment instruments of their own. The new criteria for prodromal AD/MCI due to AD may overcome this problem by including biomarkers for the diagnosis of the condition \[[@CR85]\]. Nevertheless, the differentiation between MCI and dementia, as described in the new National Institute on Aging and Alzheimer's Association criteria, rests on the determination of whether there is significant interference in the ability to function at work or in usual daily activities \[[@CR86]\]. Therefore, the identification of IADL deficits in MCI as an early phase of AD is absolutely essential for clinical practice. Regarding the effect sizes, the differences between MCI subjects and healthy controls are not only statistically significant but also clinically relevant and can be considered quite robust. Defining a threshold of functional impairment, however, remains a difficult task. MCI is primarily a neuropsychologically defined construct. To give recommendations on exact thresholds, IADL measures which are specifically designed for and/or validated in MCI populations are needed first. If this is achieved, future criteria for MCI could postulate mild deficits in IADL functioning (that is, more than 1.5 standard deviations below healthy controls) in at least one of the following domains: financial abilities, keeping appointments, task completion time, task accuracy or remembering recent events.

It appears evident on the basis of this review that patients with MCI with IADL deficits are more likely to convert to dementia than are patients with MCI without IADL restrictions \[[@CR27],[@CR32]\]. In fact, the presence of acquired IADL disability not due to a concomitant physical condition seems to be in itself a valid marker of prodromal AD. Studies assessing structural brain functioning and IADL impairment in MCI simultaneously \[[@CR87]\] can help to identify relevant biomarkers of IADL deficits and at-risk individuals. Failure to detect an individual's functional impairments might preclude training of these activities by occupational therapy or lead to neglecting needs and providing an inadequate amount of care from community-based services. Deterioration in IADL abilities, rather than cognition impairments, predicted a greater need of home help services in AD \[[@CR88]\].

Conclusions {#Sec25}
===========

Although there was no uniform agreement about which IADL domains are typically---that is, characteristically and/or specifically---impaired in MCI and which types of instruments may detect those best, a clear tendency nevertheless emerged, with activities requiring higher cognitive processes being consistently affected. Also, the use of performance-based measures and technology-related items seems to be promising.

Future research should concentrate on both the thorough validation of established instruments and the development of new ones. As new instruments for IADL functioning in MCI are being developed, researchers should include items measuring the domains of financial capacities, keeping appointments, task completion time and task accuracy. Moreover, studies comparing the three assessment modalities---that is, self-report, informant-report rating and performance-based---in the same sample are needed. In the long run, this could lead to a more precise definition of functional impairment in MCI in terms of quantifiable cutoff scores.

**Competing interests**

The authors declare that they have no competing interests.

**Authors' contributions**

KJ conducted the literature search with support from MD, LH and LF and wrote the first draft of the manuscript. MEr, FP and LN added and analyzed literature regarding technology use. PJC, KP, EL and SAMS provided valuable input for restructuring parts of the manuscript. CW, RB, BD, MEw, EG, MGK, PM, JLM, MGMOR, JMO, ES, TS, RS, MT and BW were involved in revising the manuscript. All authors read and approved the final manuscript.

KJ received a scholarship from the Robert-Bosch Stiftung, Germany. MEw is supported by the European Commission Marie Curie Training Grant (PCIG12-GA-2012-334259) and the LMUexcellent Investment Fund. FP thanks LabEx DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease) for their support. The work of SAMS is part of a fellowship project of Alzheimer Nederland, WE.15-2012-02. CW is currently receiving an ALF young researcher grant from Region Skåne, Sweden.
